Business News • PR NewsWire • Liquid Biotech USA, Inc. Announces Completion of Proof-of-Concept (POC) Clinical Study that Triggers a $1M Milestone Payment from Oncolys Biopharma, Inc.

Liquid Biotech USA, Inc. Announces Completion of Proof-of-Concept (POC) Clinical Study that Triggers a $1M Milestone Payment from Oncolys Biopharma, Inc.

Liquid Biotech USA, Inc. Announces Completion of Proof-of-Concept (POC) Clinical Study that Triggers a $1M Milestone Payment from Oncolys Biopharma, Inc.

PHILADELPHIA, April 5, 2016 /PRNewswire/ -- Liquid Biotech USA, Inc. (LB) today announced that a combination of pre-clinical and clinical data from a recently completed study supports its diagnostic bladder and lung cancer test in a clinical setting. The completion of the clinical...

View More : http://www.prnewswire.com/news-releases/liquid-biotech-usa-inc-announces-completion-of-proof-of-concept-poc-clinical-stu...

Releted News by prnewswire

Golfers Needing Spine Surgery Recruited For New Study To Get Them Back On Course

ABR Dynamic Funds Adds Two Industry Experts